Jacob Hughes
Stock Analyst at Wells Fargo
(2.25)
# 2,630
Out of 4,734 analysts
31
Total ratings
57.14%
Success rate
7.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jacob Hughes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals | Maintains: Equal-Weight | $40 → $44 | $35.70 | +23.25% | 5 | May 17, 2023 | |
| PRGO Perrigo Company | Upgrades: Overweight | $54 | $23.84 | +126.51% | 1 | Sep 6, 2022 | |
| RVNC Revance Therapeutics | Maintains: Equal-Weight | $17 → $24 | $3.68 | +552.17% | 4 | Aug 25, 2022 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Equal-Weight | $12 → $13 | $3.66 | +255.19% | 3 | Aug 16, 2022 | |
| MDWD MediWound | Maintains: Overweight | $49 → $56 | $17.64 | +217.46% | 1 | May 18, 2022 | |
| EBS Emergent BioSolutions | Maintains: Equal-Weight | $46 → $38 | $9.88 | +284.62% | 3 | May 4, 2022 | |
| TEVA Teva Pharmaceutical | Maintains: Equal-Weight | $12 → $11 | $21.92 | -49.82% | 11 | Jul 29, 2021 | |
| BHC Bausch Health Companies | Maintains: Equal-Weight | $18 → $17 | $7.44 | +128.49% | 3 | Oct 28, 2020 |
Amphastar Pharmaceuticals
May 17, 2023
Maintains: Equal-Weight
Price Target: $40 → $44
Current: $35.70
Upside: +23.25%
Perrigo Company
Sep 6, 2022
Upgrades: Overweight
Price Target: $54
Current: $23.84
Upside: +126.51%
Revance Therapeutics
Aug 25, 2022
Maintains: Equal-Weight
Price Target: $17 → $24
Current: $3.68
Upside: +552.17%
Ironwood Pharmaceuticals
Aug 16, 2022
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $3.66
Upside: +255.19%
MediWound
May 18, 2022
Maintains: Overweight
Price Target: $49 → $56
Current: $17.64
Upside: +217.46%
Emergent BioSolutions
May 4, 2022
Maintains: Equal-Weight
Price Target: $46 → $38
Current: $9.88
Upside: +284.62%
Teva Pharmaceutical
Jul 29, 2021
Maintains: Equal-Weight
Price Target: $12 → $11
Current: $21.92
Upside: -49.82%
Bausch Health Companies
Oct 28, 2020
Maintains: Equal-Weight
Price Target: $18 → $17
Current: $7.44
Upside: +128.49%